Literature DB >> 33477731

OXA-48 Carbapenemase-Producing Enterobacterales in Spanish Hospitals: An Updated Comprehensive Review on a Rising Antimicrobial Resistance.

Mario Rivera-Izquierdo1,2,3, Antonio Jesús Láinez-Ramos-Bossini4, Carlos Rivera-Izquierdo1,5, Jairo López-Gómez6, Nicolás Francisco Fernández-Martínez7,8, Pablo Redruello-Guerrero9, Luis Miguel Martín-delosReyes1, Virginia Martínez-Ruiz1,3,10, Elena Moreno-Roldán1,3, Eladio Jiménez-Mejías1,3,10,11.   

Abstract

Carbapenemase-producing Enterobacterales (CPE) are significant contributors to the global public health threat of antimicrobial resistance. OXA-48-like enzymes and their variants are unique carbapenemases with low or null hydrolytic activity toward carbapenems but no intrinsic activity against expanded-spectrum cephalosporins. CPEs have been classified by the WHO as high-priority pathogens given their association with morbidity and mortality and the scarce number of effective antibiotic treatments. In Spain, the frequency of OXA-48 CPE outbreaks is higher than in other European countries, representing the major resistance mechanism of CPEs. Horizontal transfer of plasmids and poor effective antibiotic treatment are additional threats to the correct prevention and control of these hospital outbreaks. One of the most important risk factors is antibiotic pressure, specifically carbapenem overuse. We explored the use of these antibiotics in Spain and analyzed the frequency, characteristics and prevention of CPE outbreaks. Future antibiotic stewardship programs along with specific preventive measures in hospitalized patients must be reinforced and updated in Spain.

Entities:  

Keywords:  OXA-48; Spain; antibiotic stewardship; carbapenem; carbapenemase; enterobacteria; multiresistant; outbreak

Year:  2021        PMID: 33477731      PMCID: PMC7832331          DOI: 10.3390/antibiotics10010089

Source DB:  PubMed          Journal:  Antibiotics (Basel)        ISSN: 2079-6382


  110 in total

1.  Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.

Authors:  Laura Dabos; Pierre Bogaerts; Remy A Bonnin; Agustin Zavala; Pierre Sacré; Bogdan I Iorga; Daniel T Huang; Youri Glupczynski; Thierry Naas
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

2.  Intrapatient emergence of OXA-247: a novel carbapenemase found in a patient previously infected with OXA-163-producing Klebsiella pneumoniae.

Authors:  S Gomez; F Pasteran; D Faccone; M Bettiol; O Veliz; D De Belder; M Rapoport; B Gatti; A Petroni; A Corso
Journal:  Clin Microbiol Infect       Date:  2013-02-12       Impact factor: 8.067

3.  Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae.

Authors:  Anaïs Potron; Patrice Nordmann; Emilie Lafeuille; Zaina Al Maskari; Fatma Al Rashdi; Laurent Poirel
Journal:  Antimicrob Agents Chemother       Date:  2011-07-18       Impact factor: 5.191

Review 4.  Rationalizing antimicrobial therapy in the ICU: a narrative review.

Authors:  Jean-François Timsit; Matteo Bassetti; Olaf Cremer; George Daikos; Jan de Waele; Andre Kallil; Eric Kipnis; Marin Kollef; Kevin Laupland; Jose-Artur Paiva; Jesús Rodríguez-Baño; Étienne Ruppé; Jorge Salluh; Fabio Silvio Taccone; Emmanuel Weiss; François Barbier
Journal:  Intensive Care Med       Date:  2019-01-18       Impact factor: 17.440

Review 5.  Treatment of Infections Caused by Extended-Spectrum-Beta-Lactamase-, AmpC-, and Carbapenemase-Producing Enterobacteriaceae.

Authors:  Jesús Rodríguez-Baño; Belén Gutiérrez-Gutiérrez; Isabel Machuca; Alvaro Pascual
Journal:  Clin Microbiol Rev       Date:  2018-02-14       Impact factor: 26.132

6.  Carbapenemase-producing enterobacteriaceae in Spain in 2012.

Authors:  Jesús Oteo; David Saez; Verónica Bautista; Sara Fernández-Romero; Juan Manuel Hernández-Molina; María Pérez-Vázquez; Belén Aracil; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

7.  OXA-162, a novel variant of OXA-48 displays extended hydrolytic activity towards imipenem, meropenem and doripenem.

Authors:  Murat Kasap; Sinem Torol; Fetiye Kolayli; Devrim Dundar; Haluk Vahaboglu
Journal:  J Enzyme Inhib Med Chem       Date:  2012-07-30       Impact factor: 5.051

Review 8.  Current status of ESKAPE microorganisms in Spain: Epidemiology and resistance phenotypes.

Authors:  J Sánchez-López; R Cantón
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

9.  Molecular Epidemiology of OXA-48 and NDM-1 Producing Enterobacterales Species at a University Hospital in Tehran, Iran, Between 2015 and 2016.

Authors:  Hamid Solgi; Shoeib Nematzadeh; Christian G Giske; Farzad Badmasti; Fredrik Westerlund; Yii-Lih Lin; Gaurav Goyal; Vajihe Sadat Nikbin; Amir Hesam Nemati; Fereshteh Shahcheraghi
Journal:  Front Microbiol       Date:  2020-05-28       Impact factor: 5.640

View more
  6 in total

Review 1.  OXA-48-Like β-Lactamases: Global Epidemiology, Treatment Options, and Development Pipeline.

Authors:  Sara E Boyd; Alison Holmes; Richard Peck; David M Livermore; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2022-07-20       Impact factor: 5.938

2.  Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.

Authors:  Isabel Carvalho; Nadia Safia Chenouf; José António Carvalho; Ana Paula Castro; Vanessa Silva; Rosa Capita; Carlos Alonso-Calleja; Maria de Lurdes Nunes Enes Dapkevicius; Gilberto Igrejas; Carmen Torres; Patrícia Poeta
Journal:  PLoS One       Date:  2021-05-04       Impact factor: 3.240

3.  Carbapenem-Resistant Organisms Isolated in Surgical Site Infections in Benin: A Public Health Problem.

Authors:  Carine Laurence Yehouenou; Reza Soleimani; Arsène A Kpangon; Anne Simon; Francis M Dossou; Olivia Dalleur
Journal:  Trop Med Infect Dis       Date:  2022-08-21

Review 4.  Extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacterales bloodstream infection after solid organ transplantation: Recent trends in epidemiology and therapeutic approaches.

Authors:  Elena Pérez-Nadales; Mario Fernández-Ruiz; Belén Gutiérrez-Gutiérrez; Álvaro Pascual; Jesús Rodríguez-Baño; Luis Martínez-Martínez; José María Aguado; Julian Torre-Cisneros
Journal:  Transpl Infect Dis       Date:  2022-06-28

5.  In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing Klebsiella pneumoniae Clinical Isolates.

Authors:  Uthaibhorn Singkham-In; Netchanok Muhummudaree; Tanittha Chatsuwan
Journal:  Antibiotics (Basel)       Date:  2021-12-17

6.  How COVID-19 Has Influenced Public Interest in Antimicrobials, Antimicrobial Resistance and Related Preventive Measures: A Google Trends Analysis of Italian Data.

Authors:  Andrea Maugeri; Martina Barchitta; Guido Basile; Antonella Agodi
Journal:  Antibiotics (Basel)       Date:  2022-03-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.